Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Metastatic Castration-Resistant Prostate Cancer Patients 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 18Paclitaxel 13Erlotinib Hydrochloride 13Bevacizumab 13Radiotherapy 12Gemcitabine 9Pemetrexed 7Cisplatin 7Gefitinib 6Docetaxel 6Taxes 4Cetuximab 4pegfilgrastim 3Radiosurgery 2Radiation 2Nivolumab 2Neoadjuvant Therapy 2Irinotecan 2Chemotherapy, Adjuvant 2Bortezomib 2pegylated granulocyte colony-stimulating factor 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1Watchful Waiting 1Vinorelbine 1Video-Assisted Surgery 1Topotecan 1Thalidomide 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma, Bronchiolo-Alveolar × irofulven × Clear all
NCT00003666 2016-07-20

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
36 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡